Improvement after a supplement is not the same as a comparative result
Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.
Selected research topic
Some measured outcomes improved in human comparison studies. Read these findings with their populations and conditions.
Some findings concern patients or people with a deficiency.
What the comparison group used was not confirmed.
Patient group · Single ingredientInsomnia Severity Index (ISI)
Pittsburgh Sleep Quality Index (PSQI)
Original outcome name: RSQ
This result is held for interpretation. That does not mean research found no effect.
One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.
Studies with an unspecified organism reported between-group improvement in Insomnia symptoms.
Single-ingredient studies · Includes patient groups · between-group comparison
1 publications linked to this result
Insomnia Severity Index (ISI)
Paper counts are separated by research topic below. One paper may contribute to multiple findings.
Analysis status: Public-ready
Ingredient analysis date:
How the grade was determined: C
The 39.7 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.
The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.
Papers linked to this ingredient overall: 97
Papers linked to this topic 4 · distinct papers 4 · papers with a confirmed human comparison 1 · papers needing additional review 2
A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.
The study reported improvement in this measurement.
Controlled study in people · Single ingredient · Patient group
Between-group comparison
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
The study reported improvement in this measurement.
Meta-analysis · Single ingredient · Patient group
Between-group comparison
1 paper · 1 measured outcome
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
The study reported improvement in this measurement.
Meta-analysis · Single ingredient · Patient group
Between-group comparison
1 paper · 1 measured outcome
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
The study reported improvement in this measurement.
Meta-analysis · Single ingredient · Patient group
Between-group comparison
1 paper · 1 measured outcome
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
The study needs further checking before its result can be interpreted.
Meta-analysis · Single ingredient · Patient group
The comparison could not be confirmed.
1 paper · 1 measured outcome
1 papers held from direction counts
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
The study needs further checking before its result can be interpreted.
Controlled study in people · Single ingredient · Unspecified population
Between-group comparison
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.
A reported null comparison contains a result. An abstract without an interpretable comparison leaves a question unresolved.
Count original research separately from research that reanalyzes it. Publication volume is neither replication nor a quality rating.
Findings from this ingredient alone are shown separately from those involving another supplement or medication.
No combination cautions are available to show in the current data. This does not guarantee safety.
No side-effect or combination findings are available to show from the collected papers. This does not establish safety.